MS

Evident Vascular Announces Scientific Advisory Board and New Board Member

Retrieved on: 
Monday, October 30, 2023
Health, Technology, Health Technology, Artificial Intelligence, Cardiology, Biotechnology, Yee, Intelligence, Faculty, FAHA, JD, FSVM, FACC, Manatee Memorial Hospital, LLP, RPVI, Workflow, Master of Science, VIVA, IVUS, Patient, CPO, Diagnosis, Scientific Committee on Emerging and Newly Identified Health Risks, Evidence, MS, Coronavirus Scientific Advisory Board, Management, Medical imaging, MD

Evident Vascular, Inc. a medical technology startup developing a next-generation intravascular ultrasound (IVUS) platform leveraging artificial intelligence to enable superior imaging and streamlined workflows, announced today its Scientific Advisory Board and expansion of its Board of Directors.

Key Points: 
  • Evident Vascular, Inc. a medical technology startup developing a next-generation intravascular ultrasound (IVUS) platform leveraging artificial intelligence to enable superior imaging and streamlined workflows, announced today its Scientific Advisory Board and expansion of its Board of Directors.
  • “It is our privilege to have this esteemed group of clinical experts on our Scientific Advisory Board.
  • “We are also pleased to welcome Bruce Shook to the Evident Vascular Board of Directors.
  • Evident Vascular is developing the first IVUS platform designed for peripheral interventions, with enhanced ease of use and improved image quality.

AM Best Affirms Credit Ratings of MS First Capital Insurance Limited

Retrieved on: 
Friday, October 27, 2023
Professional Services, Insurance, Finance, AD, AM Best, Credit, News, MSI, AM, Geography, Risk management, ERM, MSFC, Communication, ALL, MS, Reinsurance

AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a+” (Excellent) of MS First Capital Insurance Limited (MSFC) (Singapore).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a+” (Excellent) of MS First Capital Insurance Limited (MSFC) (Singapore).
  • The ratings also factor in rating enhancement from Mitsui Sumitomo Insurance Company Limited (MSI), for whom the ultimate parent is MS&AD Insurance Group Holdings, Inc. (MS&AD).
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .

Discover the latest advancements from ZEISS Microscopy at SfN Neuroscience 2023

Retrieved on: 
Friday, November 3, 2023
UNC, New York Institute of Technology, Biomedical sciences, System, Pathology, ZEISS, Medical laboratory, Neuraxial blockade, Assistant, Carl Zeiss AG, Associate professor, Research, University of California, San Francisco, University of North Carolina at Chapel Hill, University of British Columbia, Workflow, University, Brain, San Francisco, XRM, Microscopy, Max Planck Florida Institute for Neuroscience, Traumatic brain injury, Postdoctoral researcher, MS, Telescopic sight, Microscope, Neuroscience

WHITE PLAINS, N.Y., Nov. 3, 2023 /PRNewswire/ -- ZEISS Microscopy is highlighting two of their newest products at SfN Neuroscience 2023, in Washington, D.C., from November 12 to November 15, 2023. One delivers a new functionality to ZEISS laser scanning microscopes and the other is a new integrated system for serial block-face imaging.

Key Points: 
  • WHITE PLAINS, N.Y., Nov. 3, 2023 /PRNewswire/ -- ZEISS Microscopy is highlighting two of their newest products at SfN Neuroscience 2023, in Washington, D.C., from November 12 to November 15, 2023.
  • One delivers a new functionality to ZEISS laser scanning microscopes and the other is a new integrated system for serial block-face imaging.
  • ZEISS invites you to Discover the Power of Possibilities at SfN Neuroscience, booth #1323.
  • To learn more about ZEISS and SfN Neuroscience 2023, please visit: https://www.zeiss.com/microscopy/us/l/events/trade-shows/sfn-neuroscienc...

Bioservo Technologies: Carbonhand sales doubled in Norway

Retrieved on: 
Friday, November 3, 2023
Stroke, Patient, DSM-IV codes, MS, SEK, Pharmaceutical industry

STOCKHOLM, Nov. 3, 2023 /PRNewswire/ -- In Norway, Carbonhand has been prescribed as a medical device through the public reimbursement system for several years. Through the public reimbursement system, Carbonhand is prescribed both as an assistive device for use in the home and as an aid to return to work. The new version of Carbonhand launched this year has several improvements that allow more people to use the glove and thereby improve hand function and grip strength.

Key Points: 
  • In Norway, Carbonhand is sold through the distributor Cypromed, and so far this year they have ordered twice as many Carbonhand to Norway compared to the same period last year.
  • STOCKHOLM, Nov. 3, 2023 /PRNewswire/ -- In Norway, Carbonhand has been prescribed as a medical device through the public reimbursement system for several years.
  • So far this year, Bioservo has received orders for 27 Carbonhand at an order value of about SEK 1.8 million.
  • "As the new version of Carbonhand becomes known to therapists and patients around Norway, we are experiencing increasing demand.

Bioservo Technologies: Carbonhand sales doubled in Norway

Retrieved on: 
Friday, November 3, 2023
Stroke, Patient, DSM-IV codes, MS, SEK, Pharmaceutical industry

STOCKHOLM, Nov. 3, 2023 /PRNewswire/ -- In Norway, Carbonhand has been prescribed as a medical device through the public reimbursement system for several years. Through the public reimbursement system, Carbonhand is prescribed both as an assistive device for use in the home and as an aid to return to work. The new version of Carbonhand launched this year has several improvements that allow more people to use the glove and thereby improve hand function and grip strength.

Key Points: 
  • In Norway, Carbonhand is sold through the distributor Cypromed, and so far this year they have ordered twice as many Carbonhand to Norway compared to the same period last year.
  • STOCKHOLM, Nov. 3, 2023 /PRNewswire/ -- In Norway, Carbonhand has been prescribed as a medical device through the public reimbursement system for several years.
  • So far this year, Bioservo has received orders for 27 Carbonhand at an order value of about SEK 1.8 million.
  • "As the new version of Carbonhand becomes known to therapists and patients around Norway, we are experiencing increasing demand.

Sanofi honors 10 advocacy organizations promoting health equity solutions in underserved U.S. communities

Retrieved on: 
Thursday, November 2, 2023
RSV, Historically black colleges and universities, Social media, Black, Sickle cell disease, Physician, PASD, Equity, Navigation, Trust, Quality of life, Vaccination, Caregiver, Clinical trial, Partnership, African Americans, Nursing, Patient, Diagnosis, Coagulopathy, MS, Birth control, Vaccine, BMT, University

KO Flu and Covid will engage and communicate with seniors about influenza risks and the benefits of vaccination by utilizing boxing events in historically disadvantaged communities.

Key Points: 
  • KO Flu and Covid will engage and communicate with seniors about influenza risks and the benefits of vaccination by utilizing boxing events in historically disadvantaged communities.
  • This service will assist patients and caregivers by clarifying treatment options, providing biomarker testing education, and identifying clinical trial options.
  • Transplant Equity and Awareness for Sickle Cell Disease will address low stem cell donation and the underutilization of Bone Marrow Transplant (BMT) treatment.
  • This multi-organization partnership strives to lead an educational awareness program targeting Black and Hispanic communities in the US.

Massage Envy Announces Scholarship Sweepstakes Winners

Retrieved on: 
Thursday, November 2, 2023
Skin care, AL, Massage, NO, MS, Massage Envy, Beauty salon

SCOTTSDALE, Ariz., Nov. 2, 2023 /PRNewswire/ -- Massage Envy, a national leader in massage and skincare services, today announced the winners drawn in September under the Massage Envy National Scholarship Sweepstakes for Massage Therapists.

Key Points: 
  • "As we close out this year's scholarship sweepstakes, Massage Envy is proud to have awarded 96 talented scholars a chance to attend Massage Therapy school," said Beth Stiller, CEO, Massage Envy.
  • Under the new Massage Envy National Scholarship Sweepstakes for Massage Therapists, each awardee will receive a $2,500 scholarship that can be used to attend any massage school of their choice.
  • Scholarship recipients do not have to work at a Massage Envy franchised location upon graduation from massage school.
  • Massage Envy, based in Scottsdale, Arizona, is a national franchisor and does not independently own or operate any of the Massage Envy franchised locations nationwide.

Tri-M® Music Honor Society and National Federation of State High School Associations Present 10 Schools Grants to Start Tri-M® Chapters

Retrieved on: 
Thursday, November 2, 2023
Tri-M, National Association, Faculty, Performing arts, National Association for Music Education, Presentation High School, National Executive Board of the Boy Scouts of America, Superior High School, Hope, Human, Music, National Federation of State High School Associations, Velma Jackson High School, National Federation of Music Clubs, Blaisdell, Lockhart High School, Learning, Growth, NFHS, Student, Saint Marys Area School District, School, Rex Putnam High School, Reindeer, Adviser, Caribou High School, MS, Parent, Nursing, Entertainment, Management

RESTON, Va., Nov. 2, 2023 /PRNewswire-PRWeb/ -- The Tri-M® Music Honor Society (a program of National Association for Music Education, or NAfME) extends gratitude to the National Federation of State High School Associations (NFHS) for continuing its generous collaboration, providing grants to 10 new Tri-M® chapters during the 2023–2024 academic year. The 10 schools receiving grants have been announced.

Key Points: 
  • RESTON, Va., Nov. 2, 2023 /PRNewswire-PRWeb/ -- The Tri-M® Music Honor Society (a program of National Association for Music Education , or NAfME) extends gratitude to the National Federation of State High School Associations (NFHS) for continuing its generous collaboration, providing grants to 10 new Tri-M® chapters during the 2023–2024 academic year.
  • "The National Federation of State High School Associations is excited to help launch these schools' participation in Tri-M," Dr. James Weaver, NFHS Director of Performing Arts said.
  • The Tri-M® Music Honor Society is the international music honor society for middle/junior high and high school students.
  • The National Association for Music Education (NAfME) is a collaborative community that supports music educators and advocates for equitable access to music education.

Immunic Receives Notice of Allowance for United States Patent Protecting the Treatment of Relapsing Multiple Sclerosis with Vidofludimus and Its Salts

Retrieved on: 
Thursday, November 2, 2023
Patent, Food, Biotechnology, Multiple sclerosis, United States Patent and Trademark Office, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, MS, Lead, RMS, Calcium, Patient, Pharmaceutical industry, Short course immune induction therapy

"Importantly, this patent for the dose strength in RMS patients covers all salt and free acid forms of vidofludimus calcium.

Key Points: 
  • "Importantly, this patent for the dose strength in RMS patients covers all salt and free acid forms of vidofludimus calcium.
  • Vidofludimus calcium is covered by several layers of granted patents in the United States, Europe and other jurisdictions around the world.
  • In the United States, these patents provide protection into 2041, unless extended further.
  • On top of the patent exclusivity, vidofludimus calcium, as a new chemical entity, should also benefit from regulatory data protection.

Mission Therapeutics to Present Abstract at American Society of Nephrology (ASN) Kidney Week 2023

Retrieved on: 
Thursday, November 2, 2023
Kidney, Mitophagy, Trial of the century, Mission, Mitochondrion, Therapy, Treatment, DUB, Acute kidney injury, AKI, Society, Risk, Master of Science, Pharmacology, Nephrology, Safety, Patient, American Society of Nephrology, MS, Simulation, Pharmaceutical industry

CAMBRIDGE, England, Nov. 2, 2023 /PRNewswire/ -- Mission Therapeutics ("Mission"), a clinical-stage biotech company developing first-in-class therapeutics targeting mitophagy, today announces that it will present an oral abstract on its experimental drug candidate MTX652 at the American Society of Nephrology's Kidney Week in Philadelphia, from 2-5 November 2023.

Key Points: 
  • CAMBRIDGE, England, Nov. 2, 2023 /PRNewswire/ -- Mission Therapeutics ("Mission"), a clinical-stage biotech company developing first-in-class therapeutics targeting mitophagy, today announces that it will present an oral abstract on its experimental drug candidate MTX652 at the American Society of Nephrology's Kidney Week in Philadelphia, from 2-5 November 2023.
  • Mission Therapeutics is a world leader in discovering and developing novel therapeutics which promote the removal of dysfunctional mitochondria to maintain cell health and function.
  • The American Society of Nephrology is a major organization working toward a goal of a world without kidney diseases and we are excited to have the opportunity to share our progress at this important conference.
  • A Phase II trial of MTX652 in patients at risk of acute kidney injury following cardiac surgery is planned to start in Q1 2024.